Latest News of MLTX
Is MoonLake Immunotherapeutics (MLTX) the Best Guru Stock To Buy Now?
By Yahoo! Finance |
1 week ago
MoonLake Immunotherapeutics (NASDAQ:MLTX) is among the top guru stocks to buy. MLTX is a biotech company developing treatments for psoriasis, focusing on a drug called sonelokimab. With strong cash re...
MoonLake Immunotherapeutics (MLTX): Short Seller Sentiment is Bearish On This ADR Stock
By Yahoo! Finance |
1 week ago
The article discusses MoonLake Immunotherapeutics and the challenges faced by foreign companies in the U.S. market. Despite geopolitical tensions, investing in foreign stocks may offer growth opportun...
MoonLake Immunotherapeutics (MLTX): One of Oppenheimer's Top Stock Picks For the Next 12 Months
By Yahoo! Finance |
1 month ago
Oppenheimer's top stock picks for the next 12 months include MoonLake Immunotherapeutics (NASDAQ: MLTX), ranking 5th. MLTX, a biotech company, is developing a treatment for various ailments. Although ...
-
We're Interested To See How MoonLake Immunotherapeutics (NASDAQ:MLTX) Uses Its Cash Hoard To Grow
By Yahoo! Finance | 1 month agoShareholders can profit from a money-losing business by investing in a promising company at a low price. MoonLake Immunotherapeutics (NASDAQ:MLTX) with a solid cash reserve of US$520m and cash burn of...